rss
Heart 2009;95:1303-1308 doi:10.1136/hrt.2008.161273
  • Review

Non-cardiac surgery and antiplatelet therapy following coronary artery stenting

  1. M Luckie,
  2. R S Khattar,
  3. D Fraser
  1. Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK
  1. Dr D Fraser, Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK; douglas.fraser{at}cmmc.nhs.uk
  • Accepted 23 December 2008
  • Published Online First 12 February 2009

Abstract

Coronary artery stenting is increasingly used as a treatment for coronary artery disease. A period of antiplatelet therapy is mandatory following coronary stenting, in order to minimise the risk of stent thrombosis. About 5% of patients who undergo coronary stenting will require non-cardiac surgery within 12 months, and the management of antiplatelet therapy in this setting is complex, requiring a balance between the risks of both operative haemorrhage and stent thrombosis. The available evidence to guide decision-making in the management of antiplatelet therapy in this setting is reviewed.

Footnotes

  • Competing interests: None.

Responses to this article

Latest from Education in Heart

Latest from Education in Heart

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.